AC
Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
$1.85 +7.56% (+$0.13)
1M -16.29%
Market Cap $72.8M
P/E Ratio -
Div. Yield -
ROE 70.14%
Bulios Fair Price
$1.7
8.1% downside
Trenutna cena
$1.85
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ACRV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.84x
PEG N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 12.93%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 70.14%
ROA 74.91%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 7.99x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
10 /100
Unstable EPS volatility 62.28%
Profitable years 0
Beta 1.93x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACRV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Blume-Jensen
Employees
75
Headquarters
Watertown
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report